Napredna pretraga

Pregled bibliografske jedinice broj: 462003

Hedgehog-Gli signaling pathway interactions and therapeutic potential in proliferative tumors of the ovary


Levanat, Sonja; Čretnik, Maja; Musani, Vesna; Ozretić, Petar; Orešković, Slavko
Hedgehog-Gli signaling pathway interactions and therapeutic potential in proliferative tumors of the ovary // International Journal of Molecular Medicine / Spandidos DA (ur.).
Atena: Spandidos DA, 2009. str. S9-S) (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni)


Naslov
Hedgehog-Gli signaling pathway interactions and therapeutic potential in proliferative tumors of the ovary

Autori
Levanat, Sonja ; Čretnik, Maja ; Musani, Vesna ; Ozretić, Petar ; Orešković, Slavko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
International Journal of Molecular Medicine / Spandidos DA - Atena : Spandidos DA, 2009, S9-S)

Skup
The 14th World Congress on Advances in Oncology and 12th Symposium on Molecular Medicine

Mjesto i datum
Loutraki, Grčka, 15.-17.10.2009

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Signaling pathwy; interactions; tumors

Sažetak
The Hh-Gli signaling pathway known as Hh-Ptc or Hh/Ptc/Smo plays a major role in embryonic development and deregulated cause developmental malformations and tumorigenesis. The pathway involvement in breast, lung, prostate, digestive tract and other tumors becoming apparent recently. Normally secreted protein Hh (Hedgehog) binds to a transmembrane protein Ptc (Patched), releasing repression of Smo (Smoothened), a membrane protein, triggering a signaling cascade within the cell, finally causing expression of target genes, a tracriptional factor Gli, onvolved in cell proliferation , PTCH itself, which limits, and finally blocks the pathway, than cyclin D, cyclin E, members of WNT and TGF beta signaling pathways. Recent findings suggest two hypothetical models of abnormal Hh-Gli pathway activation. One model (on basocellular carcinomas of ther skin (BCCs) and ovarian fibroma), suggests constitutive activation of the pathway within the cell, and doesnot require outside stimulation. The other on lung and breast tumors suggest abnormal Hh stimulation from the surrounding cells, whichcauses a strong intracellular response of the pathway. Our studies of the pathway activation on human tumors:dermoids (develop from embryonic stem cells ; they show elements of both developmental malformations and tumors) and ovarian carcinomas. Serum-starved or normally grown primary cells were treated with either cyclopamine, tomatidine or Shh protein. Some of the clone lines were additionally analyzed by immunofluorescent staining and flow cytometry (propidium-iodine staining).Immunofluorescet staining of inducible cells showed changes in protein localization before and after induction, confirming that Hh-Gli pathway is fully functional in these cells. In dermoids we showed epigenetic inactivation of PTCH gene (promoter methylation), and also the role of its haploinsufficiency, while in ovarian carcinomas inactivation of the PTCH gene is mostly a consequence of deletions in first ten exons. Also, interactions with other pathways as WNT pathway are related to some extend on borderline tumors.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

Napomena
Molim da se rad uvrsti u rubriku predavanja



POVEZANOST RADA


Projekt / tema
098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Sonja Levanat, )

Ustanove
Institut "Ruđer Bošković", Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE